Nanologica AB (publ) expands its product portfolio of purification medias for preparative chromatography and has received a trial order worth approximately SEK 3.6 million from a customer in Asia. Product development of this purification media, NLAB SivTM, has been conducted together with a customer who has a number of launched pharmaceutical products. NLAB SivTM is a non-silica-based purification media for preparative chromatography and manufacturing takes place at a manufacturing partner.

Development has been ongoing with the customer for several years and evaluation of smaller quantities has been made during this period. The customer will now test the product in its production, after which additional orders may be received. Nanologica's main focus will continue to be silica-based products for preparative chromatography, but the company will continuously evaluate additional potential products within chromatography, with the view of broadening the offer to customers and expanding the company's addressable market.